Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseasesconsensus of the Austrian IBD Working Party;Diagnose und Behandlung von Eisenmangel und Anämie bei chronisch entzündlichen Darmerkrankungen. Konsensus der österreichischen Arbeitsgruppe für CED

Zeitschrift fur Gastroenterologie

Volumn 49, Issue 5, 2011, Pages 627-632

  Gasche, Christoph ^a   Evstatiev, R ^a   Haas, T ^b   Kaser, A ^c   Knoflach, P ^d   Petritsch, W ^e   Weiss, G ^f   Reinisch, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d Klinikum Wels   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Crohn's disease; extraintestinal manifestations; inflammatory bowel disease; Iron deficiency; ulcerative colitis

Indexed keywords

IRON;

ANEMIA; ARTICLE; AUSTRIA; ENTERITIS; HUMAN; IRON DEFICIENCY; SCREENING;

ANEMIA, IRON-DEFICIENCY; AUSTRIA; GASTROENTEROLOGY; HUMANS; INFLAMMATORY BOWEL DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 79955867714     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1273324     Document Type: Article

References (64)

1. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000 6 142-150
2. Gasche C, Lomer M C., Cavill I et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004 53 1190-1197 (Pubitemid 38961976)
3. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohns disease. Aliment Pharmacol Ther 2006 24 1507-1523 (Pubitemid 44915199)
4. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004 116 (Suppl 7A) 44S-9S
5. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010 95 175-178
6. Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007 13 1545-1553
7. WHO, UNICEF, and UNU. Iron Deficiency Anemia: Assessment, Prevention and Control. Report of a joint WHO/UNICEF/UNU consultation. Geneva World Health Organization 1998 Conference Proceeding
8. Blanc B, Finch C A., Hallberg L et al. Nutritional anaemias. Report of a WHO Scientific Group. WHO Tech Rep Ser 1968 405 1-40
9. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006 107 1747-1750 (Pubitemid 43289347)
10. Beutler E, Felitti V J., Koziol J A. et al. Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002 359 211-218 (Pubitemid 34113819)
11. Waalen J, Felitti V, Gelbart T et al. Penetrance of hemochromatosis. Blood Cells Mol Dis 2002 29 418-432
12. Hollowell J G., Assendelft O W., Gunter E W. et al. Hematological and iron-related analytes reference data for persons aged 1 year and over: United States, 1988 94. Vital Health Stat 2005 11 1-156
13. Gomollon F van, Gisbert J P. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009 15 4659-4665
14. Weiss G, Goodnough L T. Anemia of chronic disease. N Engl J Med 2005 352 1011-1023
15. Semrin G, Fishman D S., Bousvaros A et al. Impaired intestinal iron absorption in Crohns disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006 12 1101-1106 (Pubitemid 44847466)
16. Nemeth E, Tuttle M S., Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004 306 2090-2093 (Pubitemid 40007660)
17. Theurl I, Aigner E, Theurl M et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009 113 5277-5286
18. Busbridge M, Griffiths C, Ashby D et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 2009 66 150-157
19. Hansen T M., Hansen N E., Birgens H S. et al. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 1983 12 353-359 (Pubitemid 14211823)
20. Bartels U, Pedersen N S., Jarnum S. Iron absorption and serum ferritin in chronic inflammatory bowel disease. Scand J Gastroenterol 1978 13 649-656 (Pubitemid 9003793)
21. Schaefer R M., Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Int Suppl 1999 69 S44-S48 (Pubitemid 29113582)
22. Bermejo F, Garcia-Lopez S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol 2009 15 4638-4643
23. Devalia V. Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay. BMJ 2006 333 385-386 (Pubitemid 44298067)
24. Bruner A B., Joffe A, Duggan A K. et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996 348 992-996 (Pubitemid 26340755)
25. Erichsen K, Hausken T, Ulvik R J. et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003 38 543-548 (Pubitemid 36609862)
26. Erichsen K, Ulvik R J., Grimstad T et al. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005 22 831-838 (Pubitemid 41564363)
27. De Silva A D., Tsironi E, Feakins R M. et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005 22 1097-1105 (Pubitemid 41779517)
28. Seril D N., Liao J, West A B. et al. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. JClin Gastroenterol 2006 40 391-397 (Pubitemid 44318157)
29. Werner T, Wagner S J., Martinez I et al. Depletion of luminal iron alters the gut microbiota and prevents Crohns disease-like ileitis. Gut 2011 60 325-333
30. Silva A D., Tsironi E de, Feakins R M. et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005 22 1097-1105 (Pubitemid 41779517)
31. Rimon E, Kagansky N, Kagansky M et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005 118 1142-1147 (Pubitemid 41363767)
32. Zlotkin S, Arthur P, Antwi K Y. et al. Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia. Pediatrics 2001 108 613-616 (Pubitemid 32786588)
33. Schreiber S, Howaldt S, Schnoor M et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. The New England Journal of Medicine 1996 334 619-623 (Pubitemid 26076567)
34. Schroder O, Mickisch O, Seidler U et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005 100 2503-2509
35. Kulnigg S, Stoinov S, Simanenkov V et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008 103 1182-1192 (Pubitemid 351677967)
36. Lindgren S, Wikman O, Befrits R et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009 44 (7) 838-895
37. Bayraktar U D., Bayraktar S. Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World J Gastroenterol 2010 16 2720-2725
38. Wells C W., Lewis S, Barton J R. et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006 12 123-130
39. Gisbert J P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008 103 1299-1307 (Pubitemid 351678000)
40. Kulnigg S, Teischinger L, Dejaco C et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009 104 1460-1467
41. Evstatiev R, Marteau P, Iqbal T et al. Efficacy and safety of standardised ferric carboxymaltose doses vs. individually calculated iron sucrose doses for IBD-associated iron deficiency anaemia: A multicentre, randomised controlled trial. Gut 2010 59 A-5075
42. Koutroubakis I E., Oustamanolakis P, Karakoidas C et al. Safety and Efficacy of Total-Dose Infusion of Low Molecular Weight Iron Dextran for Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2010 55 (8) 2327-2331
43. Lyseng-Williamson K A., Keating G M. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009 69 739-756
44. Ganzoni A M. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970 100 301-303
45. Ali M, Rigolosi R, Fayemi A O. et al. Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy. Lancet 1982 1 652-655 (Pubitemid 12179936)
46. Besarab A, Bolton W K., Browne J K. et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998 339 584-590 (Pubitemid 28385655)
47. Locatelli F, Pisoni R L., Combe C et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004 19 121-132 (Pubitemid 38072623)
48. Michael B, Coyne D W., Fishbane S et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 2002 61 1830-1839 (Pubitemid 34437938)
49. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007 369 1502-1504 (Pubitemid 46670290)
50. Chertow G M., Mason P D., Vaage-Nilsen O et al. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006 21 378-382 (Pubitemid 43159991)
51. Bailie G R., Clark J A., Lane C E. et al. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant 2005 20 1443-1449 (Pubitemid 41430619)
52. Weiss G, Gordeuk V R. Benefits and risks of iron therapy for chronic anaemias. Eur J Clin Invest 2005 35 (Suppl 3) 36-45 (Pubitemid 41783603)
53. Sazawal S, Black R E., Ramsan M et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006 367 133-143 (Pubitemid 43077129)
54. Carrier J, Aghdassi E, Platt I et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001 15 1989-1999 (Pubitemid 34014356)
55. Seril D N., Liao J, Ho K L. et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002 47 1266-1278 (Pubitemid 34606629)
56. Seril D N., Liao J, Yang C S. et al. Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet. Dig Dis Sci 2005 50 696-707 (Pubitemid 40558464)
57. Carrier J, Aghdassi E, Cullen J et al. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. JNutr 2002 132 3146-3150
58. Kabat G C., Miller A B., Jain M et al. A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women. Br J Cancer 2007 97 118-122 (Pubitemid 47012094)
59. Cross A J., Gunter M J., Wood R J. et al. Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study. Int J Cancer 2006 118 3147-3152
60. Senesse P, Meance S, Cottet V et al. High dietary iron and copper and risk of colorectal cancer: a case-control study in Burgundy, France. Nutr Cancer 2004 49 66-71 (Pubitemid 39299128)
61. Kato I, Dnistrian A M., Schwartz M et al. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer 1999 80 693-698 (Pubitemid 29066280)
62. Seril D N., Liao J, West A B. et al. High-iron diet: foe or feat in ulcerative colitis and ulcerative colitis-associated carcinogenesis. JClin Gastroenterol 2006 40 391-397 (Pubitemid 44318157)
63. Lakatos L, Mester G, Erdelyi Z et al. Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients. Orv Hetil 2006 147 175-181 (Pubitemid 47470400)
64. Stein J, Hartmann F, Dignass A U. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010 7 599-610